Редактирование: IL3

Interleukin-3 precursor (IL-3) (Hematopoietic growth factor) (Mast cell growth factor) (MCGF) (Multipotential colony-stimulating factor) (P-cell-stimulating factor)

==Publications==

{{medline-entry
|title=Comparison of erythropoietic response to androgen in young and old senescence accelerated mice.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/10515662
|abstract=In this study, to clarify whether the functional capacity of hemopoietic progenitor cells and the micro-environment of aged mice are identical with those of the young, we investigated the changes in the number of hemopoietic progenitor cells and the production of regulatory cytokines from splenic cells as well as changes in the serum levels of cytokine in senescence-accelerated mice (SAM) after administration of 19-nandrolone decanoate (19-ND), a synthetic androgenic anabolic steroid. 19-ND induced an increase in erythroid colony-forming units (CFU-E), erythroid burst-forming units (BFU-E), and granulocytic-macrophage committed progenitor cells (CFU-GM) in bone marrow and spleen; especially remarkable increases were observed in the splenic CFU-E in both young and old mice. Antigen expression analysis of hemopoietic organs revealed that total TER-119  cells per spleen of young and old mice with androgen treatment rose 2.6- and 3.2-fold over their respective control values. The responsiveness of hemopoietic progenitor cells to androgen did not change with age. Injection of 19-ND into young and old mice markedly enhanced the erythropoietin levels but not [[IL3]] and GM-CSF levels in the serum of both groups. Cytokine production assessed by pokeweed mitogen-stimulated spleen condition medium showed an age-related decline. Androgen treatment could not influence IL-3 and GM-CSF production of spleen. These findings suggest that the spleen of both old and young mice served as the major site of regenerative repopulation of hemopoietic progenitors, especially the late erythroid progenitors in 19-ND-treated mice. The proliferative reserve of erythropoiesis with androgen treatment in aged mice was not reduced more than that in treated-young mice.
|mesh-terms=* Aging
* Anabolic Agents
* Androgens
* Animals
* Bone Marrow Cells
* Erythropoiesis
* Erythropoietin
* Female
* Fluorometry
* Granulocyte-Macrophage Colony-Stimulating Factor
* Hematopoietic Stem Cells
* Interleukin-3
* Leukocytes, Mononuclear
* Mice
* Nandrolone
* Nandrolone Decanoate
* Pokeweed Mitogens
* Spleen

|full-text-url=https://sci-hub.do/10.1016/s0047-6374(99)00032-9
}}
{{medline-entry
|title=The xenotransplantation of goat and human hematopoietic cells to sheep fetuses.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/10221482
|abstract=Hematopoietic xenografts were carried out in three experiments using goat fetal liver (44-48 days, experiments I and II) or purified human CD 34  cells (experiment III) as the donor cells. Recipients were sheep fetuses at 41-47 days of gestation. Goat fetal liver cells were either injected without any pretreatment or stimulated by preincubation in a culturing in goat phytohemagglutinin-stimulated lymphocyte supernatant. Human CD 34  myeloid progenitor cells were purified from bone marrow by minimacs immunomagnetic purification and cultured in medium supplemented with stem cell factor, [[IL3]], and [[IL6]]. Goat-sheep chimerism was assessed by flow cytometry analysis (FCA) of peripheral blood and bone marrow cells using a mouse anti-goat CD 45 monoclonal antibody and by karyotype analysis of peripheral blood from goat/sheep chimeras. Human cell engraftment was assessed by polymerase chain reaction amplification of the human DAX1 gene in blood and bone marrow DNA from sheep which had received human cells. In the three experiments, a mean of 76% (26 of 34) of injected fetuses were born alive without any clinical evidence of graft-versus-host disease. Three lambs were found to be goat/sheep chimeric after flow cytometry analysis (peripheral blood and bone marrow) and karyotype (peripheral blood) analysis. Both tissues continued to express goat cells at 6 or 12 months (last assessment) depending on the experiment. No human chimerism was detected using polymerase chain reaction amplification in peripheral blood and bone marrow of any of the six sheep grafted with human cells. These data and those also obtained on other species (human, pig/sheep) show that it is possible to carry out hematopoietic xenografts using the sheep fetus as recipient provided both donor and recipient fetal cells are processed during the period of tolerance to foreign antigens.
|mesh-terms=* Aging
* Animals
* Female
* Fetus
* Flow Cytometry
* Goats
* Graft Survival
* Hematopoietic Stem Cell Transplantation
* Humans
* Karyotyping
* Sheep
* Transplantation, Heterologous

|full-text-url=https://sci-hub.do/10.1097/00007890-199904150-00009
}}